$CME · CME GROUP INC.
CME Group filed its Q3 FY2026 Form 10-Q. Revenue grew 13% YoY to $1.737B, net income rose 14% to $1.037B, and diluted EPS was $2.89. Operating margin expanded to 65.7% from 63.3% a year earlier.
- Q3 revenue of $1,737.3 million was up 13% YoY.
- Clearing and transaction fees of $1,378.1 million rose 12% YoY.
- Market data and information services revenue of $243.1 million rose 20% YoY.
- Diluted EPS was $2.89 versus $2.49 a year ago.
- Nine-month operating cash flow was $3,292.9 million versus $3,143.2 million.
CME shares are up 0.03% since filing at $306.50 on a $110.21B market cap, indicating the double-digit Q3 was treated as expected.
CME's double-digit Q3 revenue and EPS growth with 65.7% operating margin confirms pricing power and exchange volume strength.
CME's 20% market data growth shows exchanges monetizing data faster than transaction fees.
Filing flags duplicative cloud migration costs while running on-premise and Google Cloud, plus transaction-tax and 60/40 tax-treatment policy risks.
Get filings like this before the market reacts.
Real-time SEC filing alerts, AI summaries, and a free daily digest — plus portfolio tracking that ties filings to your positions.